2008
DOI: 10.1007/s00216-008-2105-x
|View full text |Cite
|
Sign up to set email alerts
|

Single-drop analysis of various proteases in a cancer cell lysate using a capillary-assembled microchip

Abstract: Single-drop analysis of two different real sample solutions (2 microL) while simultaneously monitoring the activity of two sets of ten different proteases on a single microfluidic device is presented. The device, called a capillary-assembled microchip (CAs-CHIP), is fabricated by embedding square glass sensing capillaries (reagent-release capillaries, RRC) in the polydimethylsiloxane (PDMS) lattice microchannel, and used for that purpose. First, the performance reliability was evaluated by measuring the fluore… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
26
0

Year Published

2010
2010
2015
2015

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 26 publications
(27 citation statements)
references
References 23 publications
1
26
0
Order By: Relevance
“…Cervical cancer is currently ranked as the second most common cause of cancer-related morbidity and the third most common cause of mortality worldwide (O'Keefe et al, 2009). Treatment of cervical cancer has typically been viewed as surgical with possible adjuvant therapy versus initial radiotherapy and platinum-based chemotherapy (Yue et al, 2008;Henares, Mizutani, Sekizawa & Hisamoto, 2008;Kelly et al, 2010). But the combination treatment has significant risk of neutropenia, anemia, and thrombocytopenia side effects, also result in drug resistance.…”
Section: Introductionmentioning
confidence: 99%
“…Cervical cancer is currently ranked as the second most common cause of cancer-related morbidity and the third most common cause of mortality worldwide (O'Keefe et al, 2009). Treatment of cervical cancer has typically been viewed as surgical with possible adjuvant therapy versus initial radiotherapy and platinum-based chemotherapy (Yue et al, 2008;Henares, Mizutani, Sekizawa & Hisamoto, 2008;Kelly et al, 2010). But the combination treatment has significant risk of neutropenia, anemia, and thrombocytopenia side effects, also result in drug resistance.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, simple and multiplexed enzyme activity assay was successfully demonstrated. Since we have already shown the similar multiplexed enzyme activity assay using cell lysate sample to evaluate anticancer drug [31], present device is also expected to be applied for the real sample analysis.…”
Section: Multiplexed Glycosidase Enzyme Assay Using the Packaged Cas-mentioning
confidence: 98%
“…Furthermore, since the present CAs-CHIP-3G does not require complicated operations and bulky pump system, implementation in point-of-care applications is also expected. Furthermore, CAs-CHIP-3G allowed high success rate of close to 100% for sample introduction compared with CAs-CHIP-1G [23,30,31], and from the view point of mass production, CAs-CHIP-3G is clearly advantageous compared with 1G and 2G [35], which require one-by-one embedding of capillaries into PDMS channels.…”
Section: Fabrication and Sample Introduction Of Packaged Cas-chip-3g mentioning
confidence: 96%
See 1 more Smart Citation
“…[12][13][14][15][16][17][18][19][20][21][22][23][24][25] Especially, for enzyme activity assays, 18-23 the inner surface of a capillary is covered with a soluble coating containing reagents for the enzyme activity assay. Introducing a sample solution containing enzymes into the RRCs by a capillary action allows for the spontaneous release of the reagents and subsequent mixing with the solution.…”
mentioning
confidence: 99%